MedGenome’s OncoPept bags recognition

medgenome

Named ‘Best Overall Genomics Solution’ in 2018 MedTech Breakthrough Awards

MedGenome’s OncoPept platform of advanced genomics-based solutions designed to accelerate cancer immune-oncology research, was named the winner of the 2018 MedTech Breakthrough Awards for ‘Best Overall Genomics Solution.’

OncoPept platform is used by researchers to help identify biomarkers aimed at delivering personalised therapies including more durable, improved and responsive cancer immunotherapy treatments. It offers a personalised cancer therapy approach leveraging a novel T cell receptor binding algorithm to predict personalised cancer vaccine candidates, and provides a high-throughput multi-dimensional view of the tumour micro-environment using NGS (Next Generation Sequencing) based solutions.

The MedTech Breakthrough Awards recognise the top companies, people, platforms and products in the health, fitness and medical technology industries today. The mission of the MedTech Breakthrough Awards is to honour excellence and recognise the creativity, hard work and success of health and medical technology companies, services and products.

With over 3,000 global nominations this year for the MedTech Breakthrough Awards, the competition was incredibly fierce. Notable winners from other categories include GE, WebMD, FitBit, Philips, 23andMe, Humana, Abbott, Apple and an impressive list of top companies and startups in the MedTech industry.